DE3752048T2 - Purinderivate als Interleukin-1-Inhibitoren - Google Patents

Purinderivate als Interleukin-1-Inhibitoren

Info

Publication number
DE3752048T2
DE3752048T2 DE3752048T DE3752048T DE3752048T2 DE 3752048 T2 DE3752048 T2 DE 3752048T2 DE 3752048 T DE3752048 T DE 3752048T DE 3752048 T DE3752048 T DE 3752048T DE 3752048 T2 DE3752048 T2 DE 3752048T2
Authority
DE
Germany
Prior art keywords
interleukin
inhibitors
purine derivatives
alleviation
implicated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3752048T
Other languages
English (en)
Other versions
DE3752048D1 (de
Inventor
Gerald L Mandell
Gail W Sullivan
William J Novick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
University of Virginia UVA
Hoechst Marion Roussel Inc
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, Hoechst Marion Roussel Inc, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Application granted granted Critical
Publication of DE3752048D1 publication Critical patent/DE3752048D1/de
Publication of DE3752048T2 publication Critical patent/DE3752048T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE3752048T 1986-12-31 1987-12-30 Purinderivate als Interleukin-1-Inhibitoren Expired - Fee Related DE3752048T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94790586A 1986-12-31 1986-12-31

Publications (2)

Publication Number Publication Date
DE3752048D1 DE3752048D1 (de) 1997-05-15
DE3752048T2 true DE3752048T2 (de) 1997-10-02

Family

ID=25486973

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3752048T Expired - Fee Related DE3752048T2 (de) 1986-12-31 1987-12-30 Purinderivate als Interleukin-1-Inhibitoren

Country Status (14)

Country Link
EP (1) EP0279079B1 (de)
JP (1) JP2507012B2 (de)
KR (1) KR960015726B1 (de)
AT (1) ATE151290T1 (de)
AU (1) AU668982B2 (de)
CA (1) CA1313137C (de)
DE (1) DE3752048T2 (de)
DK (1) DK482088A (de)
ES (1) ES2103255T3 (de)
GR (1) GR3024054T3 (de)
IE (1) IE873554L (de)
IL (7) IL100536A (de)
WO (1) WO1988004928A1 (de)
ZA (1) ZA879754B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
JPH04506215A (ja) * 1989-06-13 1992-10-29 スミスクライン・ビーチャム・コーポレイション モノカイン活性干渉
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
EP0493682A3 (en) * 1990-11-30 1992-11-19 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
EP0490181A1 (de) * 1990-11-30 1992-06-17 Hoechst-Roussel Pharmaceuticals Incorporated Verwendung von Xanthinen zur Herstellung eines Medikaments mit immunsuppressiver Wirkung
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
WO1992021344A2 (en) * 1991-05-24 1992-12-10 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
JPH05194233A (ja) * 1991-06-10 1993-08-03 Hoechst Roussel Pharmaceut Inc マイクロペレットおよびそれらの製造方法
WO1993003728A1 (en) * 1991-08-27 1993-03-04 Temple University Of The Commonwealth System Of Xanthine suppression of antigen activation of t- or b-cells
ES2173871T3 (es) * 1991-10-31 2002-11-01 Univ Manchester Tratamiento de condiciones neurologicas por un compuesto inhibidor de la interleukina-1.
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
JP3830115B2 (ja) * 1997-10-06 2006-10-04 シャープ株式会社 液晶表示素子
TW561297B (en) * 1997-11-25 2003-11-11 Toshiba Corp Electrode wiring board subjected to counter measure against static electricity and display device using the same
JP3019053B2 (ja) * 1997-12-25 2000-03-13 日本電気株式会社 液晶表示装置及びその製造方法
BRPI0908107A2 (pt) 2008-02-29 2019-09-24 Concert Pharmaceuticals Inc composto derivado de xantina substituída, composição farmacêutica que compreende esse composto, métodos de tratamento de uma enfermidade ou condição em um paciente com necessidade do mesmo, método de tratamento de enfermidade crônica dos rins, do fígado, relacionada com diabetes e de claudicação intermitente
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CA2771331A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2012031138A2 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2013155465A1 (en) 2012-04-13 2013-10-17 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment

Also Published As

Publication number Publication date
AU4602793A (en) 1993-11-18
EP0279079A2 (de) 1988-08-24
ATE151290T1 (de) 1997-04-15
GR3024054T3 (en) 1997-10-31
IE873554L (en) 1988-06-30
DK482088D0 (da) 1988-08-30
DK482088A (da) 1988-10-28
JPH02501829A (ja) 1990-06-21
IL100533A (en) 1994-05-30
KR890700347A (ko) 1989-04-24
JP2507012B2 (ja) 1996-06-12
DE3752048D1 (de) 1997-05-15
CA1313137C (en) 1993-01-26
AU668982B2 (en) 1996-05-23
IL100535A (en) 1994-05-30
EP0279079A3 (de) 1990-06-13
AU637542B2 (en) 1993-05-27
WO1988004928A1 (en) 1988-07-14
ES2103255T3 (es) 1997-09-16
IL106859A (en) 1996-10-16
EP0279079B1 (de) 1997-04-09
IL106861A (en) 1997-02-18
AU1150588A (en) 1988-07-27
IL106854A (en) 1996-05-14
AU619732B2 (en) 1992-02-06
IL100536A (en) 1994-05-30
AU1291892A (en) 1992-05-14
IL84934A (en) 1994-08-26
KR960015726B1 (ko) 1996-11-20
ZA879754B (en) 1989-07-26

Similar Documents

Publication Publication Date Title
DE3752048D1 (de) Purinderivate als Interleukin-1-Inhibitoren
AU652094B2 (en) Method of inhibiting the activity of leukocyte derived cytokines
DE69214397T2 (de) 2-Substituierte Indane-2-Carboxyalkyl-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
NO2006018I2 (no) Entekavir
DK599789A (da) 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler
FI935944A (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
DE3855956T2 (de) Verwendung einer Triglyceridverbindung als Hämolysishemmer
ATE46332T1 (de) Spiro-imidazolidine als aldose-reduktaseinhibitoren.
DE69737609D1 (de) Prenyl transferase inhibitoren
ATE72430T1 (de) Dopamin-beta-hydroxylase-inhibitoren.
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
KR860014540U (ko) Nc 선반의 습동면 기브 조절 고정장치
FIU920135U0 (fi) Begraensvare till bloevbehandlingsanordning
IT8823094A0 (it) Uso di composti a struttura azometinica come inibitori di corrosione
IT8719436V0 (it) Tronchesina per alvorazioni su componenti elettronici, il cui angolo di apertura massima e'determinato dalla opportuna profilatura delle due branche
SE8403465D0 (sv) Lock till olika typer av toilettstolar

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, INC., KANSAS CITY, MO., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee